Pacira Biosciences, Stock Cash Flow From Operations

PCRX Stock

USD 21.81 0.44 1.98%

By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Pacira BioSciences,'s long-term financial health and intrinsic value.

Other Current Liab Total Assets

Build AI portfolio with Pacira Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pacira BioSciences, Company Cash Flow From Operations Analysis

Pacira BioSciences,'s Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Operating Cash Flow

EBITDA

-

Taxes

More About Cash Flow From Operations | All Equity Analysis

Current Pacira BioSciences, Cash Flow From Operations

189.39 M

Most of Pacira BioSciences,'s fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pacira BioSciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pacira Cash Flow From Operations Driver Correlations

Understanding the fundamental principles of building solid financial models for Pacira BioSciences, is extremely important. It helps to project a fair market value of Pacira Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Pacira BioSciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pacira BioSciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pacira BioSciences,'s interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.46	0.89	0.27	0.64	0.91	0.95	0.39	0.93	0.94	0.63	0.94	0.65	0.95	-0.06	0.65	0.84	0.89	0.07	0.64	0.89	0.55	0.88
Total Stockholder Equity	0.97		0.5	0.84	0.3	0.68	0.85	0.98	0.43	0.84	0.9	0.52	0.91	0.66	0.96	0.02	0.6	0.83	0.9	0.03	0.51	0.94	0.66	0.92
Current Deferred Revenue	0.46	0.5		0.49	-0.15	0.51	0.45	0.43	0.71	0.38	0.54	-0.01	0.27	0.42	0.37	0.49	0.36	0.67	0.56	0.43	0.2	0.43	0.52	0.39
Net Debt	0.89	0.84	0.49		0.25	0.63	0.96	0.78	0.48	0.92	0.77	0.39	0.82	0.63	0.77	0.02	0.81	0.85	0.86	0.37	0.5	0.85	0.38	0.69
Retained Earnings	0.27	0.3	-0.15	0.25		0.1	0.21	0.3	-0.41	0.22	0.03	0.11	0.45	-0.35	0.29	-0.51	0.11	-0.11	0.01	-0.2	-0.02	0.53	0.25	0.46
Accounts Payable	0.64	0.68	0.51	0.63	0.1		0.68	0.68	0.51	0.58	0.63	0.07	0.58	0.38	0.65	0.2	0.44	0.77	0.78	0.08	0.24	0.63	0.55	0.54
Long Term Debt	0.91	0.85	0.45	0.96	0.21	0.68		0.81	0.38	0.95	0.79	0.39	0.88	0.64	0.8	-0.07	0.83	0.85	0.87	0.21	0.52	0.8	0.38	0.67
Net Receivables	0.95	0.98	0.43	0.78	0.3	0.68	0.81		0.31	0.81	0.89	0.56	0.93	0.61	0.99	-0.13	0.5	0.79	0.86	-0.13	0.52	0.91	0.64	0.95
Short Term Investments	0.39	0.43	0.71	0.48	-0.41	0.51	0.38	0.31		0.34	0.53	0.05	0.09	0.59	0.29	0.85	0.35	0.69	0.62	0.65	0.17	0.32	0.42	0.23
Total Liab	0.93	0.84	0.38	0.92	0.22	0.58	0.95	0.81	0.34		0.85	0.63	0.88	0.64	0.81	-0.1	0.74	0.81	0.87	0.18	0.73	0.78	0.36	0.69
Total Current Assets	0.94	0.9	0.54	0.77	0.03	0.63	0.79	0.89	0.53	0.85		0.7	0.8	0.67	0.89	0.13	0.47	0.86	0.88	0.08	0.71	0.74	0.62	0.81
Short Term Debt	0.63	0.52	-0.01	0.39	0.11	0.07	0.39	0.56	0.05	0.63	0.7		0.57	0.34	0.6	-0.18	0.11	0.33	0.46	-0.18	0.85	0.4	0.27	0.55
Intangible Assets	0.94	0.91	0.27	0.82	0.45	0.58	0.88	0.93	0.09	0.88	0.8	0.57		0.5	0.94	-0.36	0.59	0.69	0.77	-0.15	0.55	0.88	0.49	0.88
Common Stock	0.65	0.66	0.42	0.63	-0.35	0.38	0.64	0.61	0.59	0.64	0.67	0.34	0.5		0.62	0.27	0.57	0.8	0.81	0.17	0.4	0.53	0.36	0.44
Property Plant Equipment	0.95	0.96	0.37	0.77	0.29	0.65	0.8	0.99	0.29	0.81	0.89	0.6	0.94	0.62		-0.15	0.47	0.77	0.85	-0.16	0.55	0.89	0.64	0.94
Net Tangible Assets	-0.06	0.02	0.49	0.02	-0.51	0.2	-0.07	-0.13	0.85	-0.1	0.13	-0.18	-0.36	0.27	-0.15		0.09	0.26	0.2	0.59	-0.09	-0.1	0.22	-0.18
Good Will	0.65	0.6	0.36	0.81	0.11	0.44	0.83	0.5	0.35	0.74	0.47	0.11	0.59	0.57	0.47	0.09		0.64	0.67	0.38	0.31	0.56	0.07	0.33
Long Term Debt Total	0.84	0.83	0.67	0.85	-0.11	0.77	0.85	0.79	0.69	0.81	0.86	0.33	0.69	0.8	0.77	0.26	0.64		0.94	0.3	0.48	0.72	0.54	0.64
Capital Surpluse	0.89	0.9	0.56	0.86	0.01	0.78	0.87	0.86	0.62	0.87	0.88	0.46	0.77	0.81	0.85	0.2	0.67	0.94		0.17	0.57	0.81	0.57	0.71
Long Term Investments	0.07	0.03	0.43	0.37	-0.2	0.08	0.21	-0.13	0.65	0.18	0.08	-0.18	-0.15	0.17	-0.16	0.59	0.38	0.3	0.17		0.01	0.04	-0.2	-0.12
Short Long Term Debt	0.64	0.51	0.2	0.5	-0.02	0.24	0.52	0.52	0.17	0.73	0.71	0.85	0.55	0.4	0.55	-0.09	0.31	0.48	0.57	0.01		0.37	0.12	0.44
Net Invested Capital	0.89	0.94	0.43	0.85	0.53	0.63	0.8	0.91	0.32	0.78	0.74	0.4	0.88	0.53	0.89	-0.1	0.56	0.72	0.81	0.04	0.37		0.64	0.91
Net Working Capital	0.55	0.66	0.52	0.38	0.25	0.55	0.38	0.64	0.42	0.36	0.62	0.27	0.49	0.36	0.64	0.22	0.07	0.54	0.57	-0.2	0.12	0.64		0.66
Capital Stock	0.88	0.92	0.39	0.69	0.46	0.54	0.67	0.95	0.23	0.69	0.81	0.55	0.88	0.44	0.94	-0.18	0.33	0.64	0.71	-0.12	0.44	0.91	0.66

Click cells to compare fundamentals

Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Competition

Predict Pacira BioSciences,

Total Cash From Operating Activities Over Time

In accordance with the recently published financial statements, Pacira BioSciences, has 189.39 M in Cash Flow From Operations. This is 64.08% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash flow from operations for all United States stocks is 80.5% higher than that of the company.

Pacira Cash Flow From Operations Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pacira BioSciences,'s direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pacira BioSciences, could also be used in its relative valuation, which is a method of valuing Pacira BioSciences, by comparing valuation metrics of similar companies.

Pacira BioSciences, is currently under evaluation in cash flow from operations category among its peers.

Pacira BioSciences, ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pacira BioSciences,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pacira BioSciences,'s managers, analysts, and investors.

Environmental

Governance

Social

Pacira Fundamentals

	Return On Equity	-0.12
	Return On Asset	0.0356
	Profit Margin	(0.15) %
	Operating Margin	0.05 %
	Current Valuation	1.18 B
	Shares Outstanding	46.3 M
	Shares Owned By Insiders	1.78 %
	Shares Owned By Institutions	98.22 %
	Number Of Shares Shorted	5.6 M
	Price To Earning	14.34 X
	Price To Book	1.30 X
	Price To Sales	1.47 X
	Revenue	700.97 M
	Gross Profit	463.44 M
	EBITDA	32.25 M
	Net Income	(99.56 M)
	Cash And Equivalents	316.39 M
	Cash Per Share	6.90 X
	Total Debt	638.85 M
	Debt To Equity	1.10 %
	Current Ratio	3.95 X
	Book Value Per Share	17.25 X
	Cash Flow From Operations	189.39 M
	Short Ratio	9.93 X
	Earnings Per Share	(2.24) X
	Price To Earnings To Growth	(3.83) X
	Target Price	30.4
	Number Of Employees	788
	Beta	0.49
	Market Capitalization	1.03 B
	Total Asset	1.55 B
	Retained Earnings	(206.36 M)
	Working Capital	435.21 M
	Current Asset	252.58 M
	Current Liabilities	149.79 M
	Net Asset	1.55 B

About Pacira BioSciences, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pacira BioSciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pacira BioSciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pacira BioSciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VALE	Vale SA ADR
EGY	Vaalco Energy
CMCSA	Comcast Corp

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC